Atlas Trials

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

Clinical trial NCT00238615 · TERMINATED

Trial details

NCT number
NCT00238615
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerCarcinoma, Non-Small-Cell Lung
Start date
2003-03-01
Primary completion
2009-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.